In Vitro Susceptibility of Leishmania infantum to Artemisinin Derivatives and Selected Trioxolanes
- Autores: Albuquerque A, Cabral LIL, Campino L, Cortes S, Cristiano MLS, Lopes L
- Ano de Publicação: 2015
- Journal: Antimicrobial Agents and Chemotherapy
- Link: http://www.ncbi.nlm.nih.gov/pubmed/26014947
Leishmaniasis is among the world’s most neglected diseases. Currently available drugs for treatment present drawbacks, urging the need for more effective, safer, and cheaper drugs.
Ler mais
